DEA warns over growing prevalence of xylazine in illicit fentanyl supply
The Center Square -

(The Center Square) – The U.S. Drug Enforcement Agency has issued another warning about the growing prevalence of a veterinary sedative in illicit fentanyl supply. For years, dealers have been mixing xylazine, a non-opioid tranquilizer approved for animal use, with fentanyl and other drugs to increase potency and profits. In 2022, about a quarter of all powered fentanyl contained xylazine. In 2023, about 30% of all powered fentanyl contained xylazine, DEA...

In related news